Paul Hudson, chief executive officer of Sanofi, visiting the drugmaker’s exhibition stand at the Viva Technology conference at Porte de Versailles exhibition centre in Paris, France, on Friday. Photograph: Nathan Laine/Bloomberg

Sanofi will invest about €400 million in research and development of next-generation vaccines using mRNA technologies which proved their efficiency in(...)

Vaccination against Covid-19 has been developed and is being tested. File photograph: iStock

We are all exhausted. The Covid-19 pandemic has hit the world hard. While we know our sacrifices are for the best, right now we also need to know w(...)